nembutal medication information No Further a Mystery

nembutal medication information No Further a Mystery

Blog Article

pentobarbital will reduce the level or influence of nitrendipine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Importance Not known.

pentobarbital will reduce the level or outcome of methylprednisolone by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Watch.

pentobarbital will reduce the level or impact of colchicine by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Check.

pentobarbital will lower the level or impact of doxorubicin by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Observe.

pentobarbital will minimize the level or outcome of diazepam intranasal by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Observe. Solid or moderate CYP3A4 inducers might raise price of diazepam elimination; for that reason, efficacy of diazepam may be reduced.

Contraindicated (1)pentobarbital decreases levels of vandetanib by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Avoid coadministration with potent CYP3A4 inducers; these medicines lessen publicity to vandetanib by as much as 40%.

Check Carefully (1)pentobarbital will minimize the level or effect of mestranol by affecting hepatic/intestinal enzyme CYP3A4 metabolism.

pentobarbital will minimize the extent or impact of loratadine by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.

pentobarbital will lower the extent or result of ripretinib by affecting hepatic/intestinal enzyme CYP3A4 metabolism.

pentobarbital will lessen the extent or impact of diazepam by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Observe.

pentobarbital will minimize the extent or effect of guanfacine by click here affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Watch Closely. Strong or reasonable CYP3A4 inducers noticeably lower guanfacine plasma concentrations and elimination half-life.

pentobarbital will decrease the extent or influence of cilostazol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep track of.

pentobarbital raises toxicity of ifosfamide by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep track of. CYP3A4 inducers may well raise the metabolism of ifosfamide to its active alkylating metabolites.

pentobarbital increases toxicity of methoxyflurane by rising metabolism. Contraindicated. Elevated metabolism of methoxyflurane to nephrotoxic compounds.